NCT02064621View on ClinicalTrials.gov

CKD-330 Drug-Drug Interaction Study (Candesartan)

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Hypertension
Interventions
DRUG

Candesartan 32mg

Candesartan 32mg 1T, PO, QD for 9days

DRUG

Candesartan 32mg/Amlodipine 10mg

Candesartan 32mg 1T, PO, QD for 9days/Amlodipine 10mg 1T, PO, QD for 9days

Trial Locations (1)

Unknown

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY